Cargando…

Magnolol may contribute to barrier function improvement on imiquimod-induced psoriasis-like dermatitis animal model via the downregulation of interleukin-23

Psoriasis is a chronic, recurrent, immune-mediated disease involving the skin and joints. Epidermal hyperproliferation, abnormal keratinocyte differentiation, angiogenesis with blood vessel dilatation, and excess T helper type-1 (Th-1) and Th-17 cell infiltration are the main histopathological featu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jiun-Wen, Cheng, Yu-Pin, Liu, Chih-Yi, Thong, Haw-Yueh, Lo, Yang, Wu, Chen-Yu, Jee, Shiou-Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967813/ https://www.ncbi.nlm.nih.gov/pubmed/33747183 http://dx.doi.org/10.3892/etm.2021.9876

Ejemplares similares

Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-induced Psoriasis-like Dermatitis in Mice
por: Guo, Jiun-Wen, et al.
Publicado: (2020)

Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel
por: He, Xiang, et al.
Publicado: (2020)

Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients
por: Yen, Ling-Jung, et al.
Publicado: (2022)

IDO-expressing Fibroblasts Suppress the Development of Imiquimod-induced Psoriasis-like Dermatitis
por: Elizei, Sanam Salimi, et al.
Publicado: (2018)

Augmentation of NAD(+) by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Lee, Seung Hoon, et al.
Publicado: (2022)

Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis
por: Yoshida, Mai, et al.
Publicado: (2023)

Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Chen, Hsin-Hua, et al.
Publicado: (2020)

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33
por: Athari, Sara Khaleghparast, et al.
Publicado: (2016)

Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis
por: Chen, Yan, et al.
Publicado: (2015)

IL-33-mediated activation of mast cells is involved in the progression of imiquimod-induced psoriasis-like dermatitis
por: Zhou, Xuyue, et al.
Publicado: (2023)

Antipsoriatic Effects of Wannachawee Recipe on Imiquimod-Induced Psoriasis-Like Dermatitis in BALB/c Mice
por: Na Takuathung, Mingkwan, et al.
Publicado: (2018)

Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist
por: Li, Qingran, et al.
Publicado: (2021)

A Promising Approach to Treat Psoriasis: Inhibiting Cytochrome P450 3A4 Metabolism to Enhance Desoximetasone Therapy
por: Guo, Jiun-Wen, et al.
Publicado: (2023)

Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis
por: Xiao, Chun-Ying, et al.
Publicado: (2020)

A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice
por: Saga, Ayami, et al.
Publicado: (2022)

Lipoxin A4 Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis via Promoting the Regression of Inflammation
por: Hu, Feng, et al.
Publicado: (2023)

Lithosepermic Acid Restored the Skin Barrier Functions in the Imiquimod-Induced Psoriasis-like Animal Model
por: Chen, Li-Ching, et al.
Publicado: (2022)

Shikonin inhibits CEBPD downregulation in IL-17-treated HaCaT cells and in an imiquimod-induced psoriasis model
por: Lan, Xiao-Ou, et al.
Publicado: (2020)

IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis
por: Hou, Yuzhu, et al.
Publicado: (2018)

Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis
por: Niu, Xue-Li, et al.
Publicado: (2019)

Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Wu, Chieh-Shan, et al.
Publicado: (2022)

The Role of Gut Microbiome in Psoriasis: Oral Administration of Staphylococcus aureus and Streptococcus danieliae Exacerbates Skin Inflammation of Imiquimod-Induced Psoriasis-Like Dermatitis
por: Okada, Karin, et al.
Publicado: (2020)

Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
por: Fujii, Kento, et al.
Publicado: (2020)

Transcriptomic Analysis of the Mechanisms for Alleviating Psoriatic Dermatitis Using Taodan Granules in an Imiquimod-Induced Psoriasis-like Mouse Model
por: Kuai, Le, et al.
Publicado: (2021)

Forsythoside A Alleviates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Regulating Th17 Cells and IL-17A Expression
por: Lin, Hsuan, et al.
Publicado: (2022)

Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy
por: Kim, Hye Ran, et al.
Publicado: (2021)

CYP3A Excipient-Based Microemulsion Prolongs the Effect of Magnolol on Ischemia Stroke Rats
por: Guo, Jiun-Wen, et al.
Publicado: (2020)

Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis
por: Liu, Jiang-Min, et al.
Publicado: (2021)

(R)-Salbutamol Improves Imiquimod-Induced Psoriasis-Like Skin Dermatitis by Regulating the Th17/Tregs Balance and Glycerophospholipid Metabolism
por: Liu, Fei, et al.
Publicado: (2020)

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020)

P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways
por: Chen, Haiming, et al.
Publicado: (2022)

Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model
por: Jabeen, Mehwish, et al.
Publicado: (2020)

IOX1 impedes host inflammation in imiquimod-triggered psoriasis
por: Shin, Joo Eun, et al.
Publicado: (2021)

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
por: Schön, Michael P., et al.
Publicado: (2018)

Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation
por: Zhang, Bin, et al.
Publicado: (2021)

Insights on the Multifunctional Activities of Magnolol
por: Zhang, Jianhong, et al.
Publicado: (2019)

Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice
por: Kjær, Thomas Nordstrøm, et al.
Publicado: (2015)

Transglutaminase 3 Reduces the Severity of Psoriasis in Imiquimod-Treated Mouse Skin
por: Piro, Maria Cristina, et al.
Publicado: (2020)

Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis
por: Salman, Hayder R., et al.
Publicado: (2023)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
por: Koutruba, Nora, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_maeam5b0v40ha02hf1r92u0tep